The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer

被引：1
|
作者：
Kilickap, Saadettin [1 ]
Arslan, Cagatay [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2010年 / 33卷 / 03期
关键词：
RECURRENCE; ADENOCARCINOMA; SURVIVAL;
D O I：
10.1097/COC.0b013e31819fe1ff
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [41] Serum determination of CA 19-9 in diagnosing pancreatic cancer: An obituary
    Pezzilli, R.
    Casadei, R.
    Calculli, L.
    Santini, D.
    Morselli-Labate, A. M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (01) : 73 - 74
  • [42] ELEVATED CA 19-9 PREDICTS UNRESECTABLE PANCREATIC-CANCER
    LAMBIASE, L
    VOGEL, SB
    FORSMARK, CE
    GASTROENTEROLOGY, 1993, 104 (04) : A418 - A418
  • [43] CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients
    Sisik, Abdullah
    Kaya, Mustafa
    Bas, Gurhan
    Basak, Fatih
    Alimoglu, Orhan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4289 - 4294
  • [44] CA 19-9 level as a criterion of unresectability in pancreatic cancer: A prospective comparison with CT and EUS.
    Rollhauser, C
    AlKawas, FH
    Benjamin, SB
    Tio, TL
    GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 557 - 557
  • [45] CA 19-9 LEVEL AS INDICATOR OF EARLY DISTANT METASTASIS AND THERAPEUTIC SELECTION IN RESECTED PANCREATIC CANCER
    Kim, Tae Hyun
    Han, Sung-Sik
    Park, Sang-Jae
    Lee, Woo Jin
    Woo, Sang Myung
    Yoo, Tae
    Moon, Sung Ho
    Kim, Seong Hoon
    Hong, Eun Kyung
    Kim, Dae Yong
    Park, Joong-Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E743 - E748
  • [46] The prediction of cancer recurrence using serum level of CA 19-9 in patients with curative operation of pancreatic cancer in the CONKO 001 cohort
    Pelzer, U.
    Bahra, M.
    Viol, R. M.
    Sinn, M.
    Stieler, J. M.
    Gebauer, B.
    Doerken, B.
    Oettle, H.
    Neuhaus, P.
    Riess, H.
    ONKOLOGIE, 2012, 35 : 161 - 161
  • [47] CA 19-9 as a Predictor of CT Response for Patients With Locally Advanced Pancreatic Cancer (LAPC)
    Moskovic, D. J.
    Carlson, P.
    Dakik, H.
    Qiao, W.
    Javle, M.
    Fogelman, D. R.
    PANCREAS, 2009, 38 (08) : 1029 - 1029
  • [48] CA 19-9 AS A PREDICTOR FOR RESPONSE AND SURVIVAL IN ADVANCED PANCREATIC CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
    Koom, Woong Sub
    Seong, Jinsil
    Kim, Yong Bae
    Pyun, Hae Ok
    Song, Si Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1148 - 1154
  • [49] CA 19-9: A surrogate to assess response to treatment in patients with metastatic pancreatic cancer (MPC).
    Diaz, Celso L.
    Cinar, Pelin
    Hwang, Jimmy
    Ko, Andrew H.
    Tempero, Margaret A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes
    Choe, Jung Wan
    Kim, Hyo Jung
    Kim, Jae Seon
    Cha, Jaehyung
    Joo, Moon Kyung
    Lee, Beom Jae
    Park, Jong-Jae
    Bak, Young-Tae
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (03) : 263 - 268
12345